Celiac Disease in Children With Type 1 Diabetes: The Usefulness of Screening— 25 years of Experience in a Single Center
Open Access
- 1 January 2025
- journal article
- Published by Wiley in Pediatric Diabetes
- Vol. 2025 (1) , 4717290
Abstract
Objective: Children with type 1 diabetes (T1D) have an increased risk of developing additional autoimmune diseases. The risk of developing celiac disease (CD) is 3–4 times higher in children with T1D. Guidelines recommend regular screening for transglutaminase antibodies (TgAbs) in T1D children. CD could be an additional burden for T1D children as both diseases affect food intake. We describe the screening practice for CD during the last 25 years in our outpatient clinic in children with T1D. Methods: We retrospectively analyzed the development of CD‐specific antibodies in our children with T1D (diabetes onset since 1998). We did not routinely recommend endoscopy when CD‐specific antibodies (TgAb, endomysium [EAb], and gliadin) were positive and patients had no CD‐specific symptoms. Results: We analyzed 304 patients. In total 122 had CD‐specific antibodies. In 98 of them, they disappeared after a short time or had been only slightly elevated. The diagnosis of CD was confirmed in 12. All 12 showed CD‐specific symptoms, such as failure to thrive, anemia, hypoglycemia, or gastrointestinal problems. In six patients, even severely elevated EAb and/or TgAb disappeared on average after 7.1 years (range 4.9–13.5 years) on gluten‐containing diet. The remaining six had antibodies without CD‐specific symptoms by the end of the observation period. In this group the duration of antibody‐positivity was 4 years (range 1.8–11.6 years). Conclusion: We conclude that even highly elevated CD‐specific antibodies can disappear in children with T1D and that screening for CD‐specific antibodies is therefore only useful in symptomatic children with T1D.Keywords
This publication has 16 references indexed in Scilit:
- Maintaining the gluten-free diet: The key to improve glycemic metrics in youths with type 1 diabetes and celiac diseaseDiabetes Research and Clinical Practice, 2023
- ISPADClinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetesPediatric Diabetes, 2022
- Early vs late histological confirmation of coeliac disease in children with new-onset type 1 diabetesDiabetologia, 2022
- European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020Journal of Pediatric Gastroenterology and Nutrition, 2020
- Global Prevalence of Celiac Disease: Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2018
- Spontaneous Normalization of Anti-Tissue Transglutaminase Antibody Levels Is Common in Children with Type 1 Diabetes MellitusDigestive Diseases and Sciences, 2011
- Guideline for the Diagnosis and Treatment of Celiac Disease in Children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and NutritionJournal of Pediatric Gastroenterology and Nutrition, 2005
- Risk of Non-Hodgkin Lymphoma in Celiac DiseaseJAMA, 2002
- Incidence of enteropathy-associated T-cell lymphoma in celiac disease: implications for children and adolescents with type 1 diabetesPediatric Diabetes, 2002
- Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphomaThe Lancet, 2000